OTC Pharmaceuticals - France

France

Revenue in the OTC Pharmaceuticals market amounts to €4,083.00 in 2024. The market is expected to grow annually by 2.97% (CAGR 2024-2029).
The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of €1,358.00 in 2024.
In global comparison, most revenue is generated in the United States (€38,250 in 2024).
In relation to total population figures, per person revenues of €62.93 are generated in 2024.
In the OTC Pharmaceuticals market, 20.1% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

Definition:
The Over-the-Counter Pharmaceuticals market includes non-prescription medications, treatments, and healthcare products that are available directly to consumers without a prescription from a licensed healthcare professional. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere such as supermarkets, and online retailers. Sales by hospitals are not included.

Structure:
The market is subdivided into Analgesics, Cold and Cough Remedies, Digestives and Intestinal Remedies, Skin Treatment, Vitamins and Minerals, Hand Sanitizer, Eye care, Sleep aids, Wound care, and Other OTC Pharmaceuticals. The Analgesics market covers non-prescription pain-relief medications which help to relief aches, pains and fevers. Cold & Cough market covers non-prescription remedies aimed at relieving nasal congestion, coughing, sore throat, and related cold discomforts. The Digestives and Intestinal Remedies market encompasses non-prescription products designed to alleviate symptoms related to digestive discomfort and intestinal issues. The Skin Treatment market includes non-prescription medications formulated to address various dermatological concerns such as acne, eczema and dryness. The Vitamins and Minerals market comprises non-prescription dietary supplements containing essential nutrients such as vitamins and minerals. The Hand sanitizer market covers sanitizing products which are applied on hands to effectively reduce the presence of bacteria and viruses. The Eye Care market covers non-prescription products to address common eye-related discomforts such as dryness, irritation or redness. The Sleep Aids market covers non-prescription products designed to promote relaxation, alleviate insomnia, and improve sleep quality. The Wound Care market includes non-prescription products designed to facilitate wound healing and prevent infection.

Additional information:
OTC Pharmaceuticals comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The OTC Pharmaceuticals market in France is experiencing steady growth due to changing customer preferences and market trends.

Customer preferences: In recent years, there has been a shift in customer preferences towards self-medication and convenience. French consumers are increasingly seeking over-the-counter pharmaceutical products that can be easily purchased without a prescription. This trend is driven by the desire for quick and easy access to healthcare solutions, as well as the growing awareness and acceptance of self-care practices. Customers are also looking for products that offer a wide range of options and cater to specific health needs.

Trends in the market: One of the key trends in the OTC Pharmaceuticals market in France is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious about the ingredients and potential side effects of pharmaceutical products, leading them to seek natural alternatives. This trend is further fueled by the growing popularity of holistic and alternative medicine practices. As a result, there has been a surge in the availability of natural and herbal OTC products in the market. Another trend in the market is the growing emphasis on preventive healthcare. French consumers are increasingly proactive about their health and are willing to invest in OTC products that help prevent illnesses and maintain overall well-being. This trend is driven by the rising healthcare costs and the desire to reduce reliance on prescription medications. As a result, there has been an increase in the availability of OTC products that focus on preventive measures such as vitamins, supplements, and immune boosters.

Local special circumstances: France has a well-established healthcare system that provides universal coverage and access to prescription medications. However, the high cost of prescription drugs and the long waiting times to see a doctor have led to an increased reliance on OTC pharmaceuticals. Additionally, the French government has implemented policies to promote self-medication and the use of OTC products, further driving the growth of the market.

Underlying macroeconomic factors: The OTC Pharmaceuticals market in France is also influenced by macroeconomic factors such as population demographics and economic growth. The aging population in France is driving the demand for OTC products, as older individuals are more likely to require medication for chronic conditions and general health maintenance. Furthermore, the stable economic growth in France has resulted in increased disposable income, allowing consumers to spend more on healthcare products, including OTC pharmaceuticals. In conclusion, the OTC Pharmaceuticals market in France is experiencing growth due to changing customer preferences towards self-medication and convenience. The market is characterized by an increasing demand for natural and herbal remedies, as well as a focus on preventive healthcare. The local special circumstances, including the well-established healthcare system and government policies, further contribute to the growth of the market. Additionally, underlying macroeconomic factors such as population demographics and economic growth play a significant role in shaping the market trends.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.